Evidence map›Paper›PMID 35452595›Full record

ArticleStem cell reports2022

The SARS-CoV-2 receptor ACE2 is expressed in mouse pericytes but not endothelial cells: Implications for COVID-19 vascular research.

Lars Muhl, Liqun He, Ying Sun, Maarja Andaloussi Mäe, Riikka Pietilä, Jianping Liu, Guillem Genové, Lei Zhang, Yuan Xie, Stefanos Leptidis and 18 more

Open access · goldAbstract read
In one paragraph

Article in Stem cell reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 55 papers.

0numbers the graph read from it
0cells of the map it votes in
55citing papers in PubMed
8.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

55 citing papers in PubMed, 83 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Vascular basement membrane laminins modulate functional zonation of cerebral microvessels.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2026
    Article
  5. Article
  6. Distinguishing subtypes of endothelial cells in the mouse aorta.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. SARS-CoV-2 and Environmental Changes: The Perfect Storm.Current issues in molecular biology · 2024
    Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

28 authors at 7 institutions in 4 countries.

Lars MuhlDepartment of Medicine, Huddinge, Karolinska Institutet, Solna, Sweden.
Liqun HeDepartment of Immunology, Genetics, and Pathology, Rudbeck Laboratory, Uppsala University, Uppsala, Sweden; Department of Neurosurgery, Tianjin Medical University General Hospital, Tianjin Neurological Institute, Key Laboratory of Post-Neuro-injury Neuro-Repair and Regeneration in Central Nervous System, Ministry of Education and Tianjin City, Tianjin 300052, China.
Ying SunDepartment of Immunology, Genetics, and Pathology, Rudbeck Laboratory, Uppsala University, Uppsala, Sweden.
Maarja Andaloussi MäeDepartment of Immunology, Genetics, and Pathology, Rudbeck Laboratory, Uppsala University, Uppsala, Sweden.
Riikka PietiläDepartment of Immunology, Genetics, and Pathology, Rudbeck Laboratory, Uppsala University, Uppsala, Sweden.
Jianping LiuDepartment of Medicine, Huddinge, Karolinska Institutet, Solna, Sweden.
Guillem GenovéDepartment of Medicine, Huddinge, Karolinska Institutet, Solna, Sweden.
Lei ZhangKey Laboratory of Ministry of Education for Medicinal Plant Resource and Natural Pharmaceutical Chemistry, National Engineering Laboratory for Resource Developing of Endangered Chinese Crude Drugs in Northwest of China, College of Life Sciences, Shaanxi Normal University, Xi'an China.
Yuan XieKey Laboratory of Ministry of Education for Medicinal Plant Resource and Natural Pharmaceutical Chemistry, National Engineering Laboratory for Resource Developing of Endangered Chinese Crude Drugs in Northwest of China, College of Life Sciences, Shaanxi Normal University, Xi'an China.
Stefanos LeptidisDepartment of Medicine, Huddinge, Karolinska Institutet, Solna, Sweden.
Giuseppe MocciDepartment of Medicine, Huddinge, Karolinska Institutet, Solna, Sweden.
Simon StrittDepartment of Immunology, Genetics, and Pathology, Rudbeck Laboratory, Uppsala University, Uppsala, Sweden.
Ahmed OsmanDepartment of Women's and Children's Health, Karolinska Institutet, Solna, Sweden.
Andrey AnisimovWihuri Research Institute and Translational Cancer Medicine Program, Biomedicum Helsinki, University of Helsinki, Helsinki, Finland.
Karthik Amudhala HemanthakumarWihuri Research Institute and Translational Cancer Medicine Program, Biomedicum Helsinki, University of Helsinki, Helsinki, Finland.
Markus RäsänenWihuri Research Institute and Translational Cancer Medicine Program, Biomedicum Helsinki, University of Helsinki, Helsinki, Finland.
Emil M HanssonDepartment of Medicine, Huddinge, Karolinska Institutet, Solna, Sweden.
Johan BjörkegrenDepartment of Medicine, Huddinge, Karolinska Institutet, Solna, Sweden; Institute of Genomics and Multiscale Biology, Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Michael VanlandewijckDepartment of Medicine, Huddinge, Karolinska Institutet, Solna, Sweden; Department of Immunology, Genetics, and Pathology, Rudbeck Laboratory, Uppsala University, Uppsala, Sweden.
Klas BlomgrenDepartment of Women's and Children's Health, Karolinska Institutet, Solna, Sweden; Department of Pediatric Oncology, Karolinska University Hospital, Stockholm Sweden.
Taija MäkinenDepartment of Immunology, Genetics, and Pathology, Rudbeck Laboratory, Uppsala University, Uppsala, Sweden.
Xiao-Rong PengCardiovascular, Renal and Metabolism, AstraZeneca BioPharmaceutical R&D, Gothenburg, Sweden.
Yizhou HuDepartment of Medical Biochemistry and Biophysics, Karolinska Institutet, Solna, Sweden.
Patrik ErnforsDepartment of Medical Biochemistry and Biophysics, Karolinska Institutet, Solna, Sweden.
Thomas D ArnoldDepartment of Pediatrics, University of California San Francisco, San Francisco, CA 94143, USA.
Kari AlitaloWihuri Research Institute and Translational Cancer Medicine Program, Biomedicum Helsinki, University of Helsinki, Helsinki, Finland.
Urban LendahlDepartment of Cell and Molecular Biology, Karolinska Institutet, Solna, Sweden. Electronic address: urban.lendahl@ki.se.
Christer BetsholtzDepartment of Medicine, Huddinge, Karolinska Institutet, Solna, Sweden; Department of Immunology, Genetics, and Pathology, Rudbeck Laboratory, Uppsala University, Uppsala, Sweden. Electronic address: christer.betsholtz@igp.uu.se.
Karolinska Institutet · SEUppsala University · SEUniversity of Helsinki · FIShaanxi Normal University · CNAstraZeneca (Sweden) · SEKarolinska University Hospital · SEUniversity of California, San Francisco · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Humanized mouse models and mouse-adapted SARS-CoV-2 virus are increasingly used to study COVID-19 pathogenesis, so it is important to learn where the SARS-CoV-2 receptor ACE2 is expressed. Here we mapped ACE2 expression during mouse postnatal development and in adulthood. Pericytes in the CNS, heart, and pancreas express ACE2 strongly, as do perineurial and adrenal fibroblasts, whereas endothelial cells do not at any location analyzed. In a number of other organs, pericytes do not express ACE2, including in the lung where ACE2 instead is expressed in bronchial epithelium and alveolar type II cells. The onset of ACE2 expression is organ specific: in bronchial epithelium already at birth, in brain pericytes before, and in heart pericytes after postnatal day 10.5. Establishing the vascular localization of ACE2 expression is central to correctly interpret data from modeling COVID-19 in the mouse and may shed light on the cause of vascular COVID-19 complications.

Indexed as

Angiotensin-Converting Enzyme 2COVID-19PericytesAnimalsCardiovascular DiseasesEndothelial CellsMiceSARS-CoV-2Ace2 protein, mouseAngiotensin-Converting Enzyme 2Angiotensin converting enzyme 2 (ACE2)COVID-19Endothelial CellspericytesSARS-CoV-2single-cell RNA-sequencingVasculature

Identifiers

PMID35452595
PMCPMC9022216
OpenAlexW4224279180

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.